BLFS — BIOLIFE SOLUTIONS INC

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 834365 ·
Last close
$24.03
Market Cap
$1.17B
52W High
$25.25
52W Low
$17.86
ADV30
506,983
Next earnings
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 27,500,000 17,496,000 27,000 1,186,000 400,906,000 22,822,000 28,676,000
Dec 2025 18,785,000 11,977,000 1,347,000 11,070,000 405,884,000 33,038,000 33,996,000
Sep 2025 28,067,000 17,921,000 -89,000 621,000 392,081,000 29,481,000 38,342,000
Jun 2025 25,421,000 16,433,000 -16,643,000 -15,838,000 387,240,000 31,902,000 40,085,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$20,115,000
Investing CF
$-71,539,000
Financing CF
$-10,924,000
CapEx
$-19,699,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.11
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-339,696,000
Inventory
$30,155,000
Receivables
$7,953,000
ST Investments
$55,889,000
EBIT TTM
$-16,603,000
Pretax Income TTM
$-12,081,000
Interest Exp TTM
$267,000
Analysts
10

Yahoo Snapshot (yfinance, live)

Total Revenue
$101,660,000
EBITDA
$4,321,000
Free Cash Flow
$6,391,125
Enterprise Value
$1,107,904,640
Total Cash
$80,996,000
Total Debt
$14,857,000
Shares Out
48,857,415
Trailing EPS
$-0.24
Book Value
$7.62
ROE
-3.1%
ROA
-0.1%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 96,214,000 -16,602,000 -4,595,000 405,884,000 33,996,000 20,115,000
Dec 2024 74,647,000 -4,477,000 -20,184,000 399,487,000 50,578,000 8,431,000
Dec 2023 68,016,000 -19,398,000 -68,002,000 412,714,000 75,051,000 -12,498,000
Dec 2022 76,239,000 -10,677,000 -139,805,000 450,229,000 86,041,000 -8,488,000

TTM Snapshot

Revenues TTM
$19,715,000
NetIncome TTM
$-20,719,000
OpCashFlow TTM
$0
Assets (Latest)
$399,487,000
Forward EPS
$0.29

Peers — same industry

TickerNameMarket CapLastDaily %
IART INTEGRA LIFESCIENCES HOLDINGS CORP $1.18B $15.19
IRMD IRADIMED CORP $1.19B $92.94
AVNS AVANOS MEDICAL, INC. $1.16B $24.75
INSP Inspire Medical Systems, Inc. $1.21B $41.99
AORT ARTIVION, INC. $1.13B $23.19

News headlines (Yahoo Finance, 1h cache)

A Look At BioLife Solutions (BLFS) Valuation As Shares Show Recent Short Term Momentum
2026-05-11 01:13 · Yahoo
BioLife (BLFS) Q1 2026 Earnings Transcript
2026-05-08 14:21 · Yahoo
BioLife Solutions, Inc. Q1 2026 Earnings Call Summary
2026-05-08 12:30 · Yahoo
BioLife Solutions, Inc. (BLFS) Tops Q1 Earnings and Revenue Estimates
2026-05-07 23:05 · Yahoo
BioLife Solutions Q1 Earnings Call Highlights
2026-05-07 21:39 · Yahoo
BioLife Solutions Reports First Quarter 2026 Financial Results
2026-05-07 20:03 · Yahoo
Three Stocks Estimated To Be Trading Below Intrinsic Value In May 2026
2026-05-07 17:38 · Yahoo
Identifying May 2026 Stocks Trading Below Estimated Value
2026-05-07 11:38 · Yahoo
Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates
2026-05-06 21:25 · Yahoo
3 Stocks Estimated To Be 25.6% To 38.5% Below Intrinsic Value
2026-05-06 17:38 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.